Nonfamilial Juvenile Polyposis Syndrome with Exon 5 Novel Mutation in SMAD 4 Gene
1Pediatric Gastroenterology and Hepatology Division, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
Insights
Juvenile polyposis syndrome (JPS), a rare genetic disorder, involves gastrointestinal polyps and increased cancer risk. This case identifies a new SMAD4 gene mutation in a child with JPS, aiding future management strategies.
Area of Science:
- Genetics
- Gastroenterology
- Oncology
Background:
- Juvenile polyposis syndrome (JPS) is an autosomal dominant disorder characterized by multiple gastrointestinal juvenile polyps.
- It significantly increases the risk of developing colorectal cancer.
- Mutations in SMAD4 and BMPR1A are the most common genetic causes of JPS.
Observation:
- An 8-year-old boy presented with recurrent rectal bleeding.
- Examination revealed numerous polyps throughout his colon.
- Histopathology confirmed the polyps were juvenile polyps.
Findings:
- Genetic analysis identified a novel mutation in the SMAD4 gene (exon 5: p.Ser144Stop) in the patient.
- This specific SMAD4 mutation has not been previously reported in the literature.
- The findings confirm a genetic basis for the patient's JPS diagnosis.
Implications:
- Genotypic diagnosis is crucial for effective management planning in JPS patients.
- Identification of novel mutations expands our understanding of JPS pathogenesis.
- This discovery may lead to more targeted therapeutic approaches for individuals with JPS.
Abstract:
Juvenile polyposis syndrome (JPS) is a rare autosomal dominant hereditary disorder, characterized by multiple juvenile polyps in the gastrointestinal tract and an increased risk of colorectal cancer. JPS is most frequently caused by mutations in the SMAD4 or BMPR1A genes. Herein, we report a child with juvenile polyposis syndrome (JPS) with a novel mutation in the SMAD4 gene. An 8-year-old boy presented with recurrent rectal bleeding and was found to have multiple polyps in the entire colon. The histology of the resected polyps was consistent with juvenile polyps. Subsequent genetic screening revealed a novel mutation in SMAD4, exon 5 (p.Ser144Stop). To the best of our knowledge, this mutation has not been reported before. Offering genotypic diagnosis for patients with JPS is an important step for strategic plan of management.
More Related Videos
Related Concept Videos
Pleiotropy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Single Nucleotide Polymorphisms-SNPs


